These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 29917250)
1. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy. Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250 [TBL] [Abstract][Full Text] [Related]
2. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer. Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in treating oesophageal cancer. Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA F1000Res; 2020; 9():. PubMed ID: 33042518 [TBL] [Abstract][Full Text] [Related]
5. Clinical and translational advances in esophageal squamous cell carcinoma. Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905 [TBL] [Abstract][Full Text] [Related]
6. Chemokines and their receptors as biomarkers in esophageal cancer. Goto M; Liu M Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415 [TBL] [Abstract][Full Text] [Related]
7. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
11. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors. Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers. Rai V; Abdo J; Agrawal DK Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834728 [TBL] [Abstract][Full Text] [Related]
13. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions. Wang M; Smith JS; Wei WQ Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis. Pan L; Zhang Y; Gao Y; Qiu J Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056 [TBL] [Abstract][Full Text] [Related]
15. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288 [TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in esophageal cancer and response to therapy. Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777 [TBL] [Abstract][Full Text] [Related]
17. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma. Huang B; Zhong N; Xia L; Yu G; Cao H Bull Math Biol; 2018 Aug; 80(8):2124-2136. PubMed ID: 29869044 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC). Samiei H; Ajam F; Gharavi A; Abdolmaleki S; Kokhaei P; Mohammadi S; Memarian A J Clin Lab Anal; 2022 Jan; 36(1):e24125. PubMed ID: 34799871 [TBL] [Abstract][Full Text] [Related]
19. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis. Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233 [TBL] [Abstract][Full Text] [Related]
20. Current Status and Future Prospects for Esophageal Cancer. Sheikh M; Roshandel G; McCormack V; Malekzadeh R Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]